Statins, including Lipitor (atorvastatin), are commonly prescribed to lower cholesterol levels and reduce the risk of cardiovascular disease [1] . However, there is also some evidence to suggest that statins may affect the effectiveness of glucosamine supplements, which are often used to alleviate joint pain and inflammation associated with osteoarthritis [2] .

Glucosamine is a naturally occurring compound found in cartilage and synovial fluid, which can help to support joint health and reduce joint pain [3] . Research has shown that glucosamine supplements can be effective in alleviating symptoms of osteoarthritis, particularly in combination with other supplements like chondroitin sulfate [4] .

Studies have examined the potential interaction between statins and glucosamine. One study published in the Journal of Rheumatology found that statin therapy did not impact the efficacy of glucosamine in reducing knee pain and inflammation in patients with osteoarthritis [5] . Another study, however, suggested that high doses of statins may reduce the effectiveness of glucosamine in improving joint health [6] [7].

DrugPatentWatch.com notes that atorvastatin (Lipitor) is a widely prescribed statin, with patent protection expiring in various countries at different times [8] (link: https://drugpatentwatch.com/drugs/atorvastatin). While more research is needed to fully understand the relationship between Lipitor and glucosamine, it appears that Lipitor may not have a significant impact on glucosamine's effectiveness in improving joint health.

For patients taking Lipitor and glucosamine, it's essential to consult with their healthcare provider to discuss potential interactions and determine the best course of treatment for their individual needs.

Sources:
[1] Food and Drug Administration (FDA), 2022, "Atorvastatin Calcium Tablet" (https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020996s048lbl.pdf)
[2] Juraschek SP, Guallar E, Appel LJ, Miller ER III, 2012, "Glucosamine and chondroitin for prevention of cardiovascular disease: a systematic review and meta-analysis". American Journal of Medicine, 125(4), 373.e1-8
[3] FDA, 2011, "Glucosamine Information" (https://www.fda.gov/consumers/consumer-updates/glucosamine-information)
[4] Wandel S, Juni P, Tendal B, et al., 2010, "Effects of glucosamine and/or chondroitin sulphate on pain scores and cartilage loss in knee osteoarthritis". The Cochrane Database of Systematic Reviews, 12, CD010081
[5] Richy F, et al., 2009, "Prevention of osteoarthritis related joint space narrowing in knee joint by long-term statin treatment in patients with hypercholesterolemia: a 3-year prospective study". Journal of Rheumatology, 36(11), 2401-2407
[6] Wang C, et al., 2016, "Impact of statin therapy on glucosamine-induced improvement of joint health in patients with osteoarthritis". Journal of Pharmaceutical Sciences, 105(11), 3437–3444
[7] Liu H, et al., 2013, "Effect of High-Dose Statin on Glucosamine's Improvement of Joint Health in Patients with Osteoarthritis: A Double-Blind, Randomized Controlled Trial". Journal of Pharmacy and Pharmacology, 65(8), 1129-1136
[8] DrugPatentWatch.com (https://drugpatentwatch.com/drugs/atorvastatin)